Drug Type Cell therapy |
Synonyms- |
Mechanism MAGEA4 modulators(Melanoma-associated antigen 4 modulators), NY-ESO-1 modulators(Cancer/testis antigen 1 modulators), PRAME modulators(PRAME nuclear receptor transcriptional regulator modulators) + [2] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hodgkin's Lymphoma | Preclinical | US | 01 Dec 2011 | |
Non-Hodgkin Lymphoma | Preclinical | US | 01 Dec 2011 |